Past exam of the learning theory: memory, cognition and psychopathology course of the University of Oxford / 2022 / 5

Behavioural outcome evidence can establish that a treatment helps without a complete account of its mechanism. It is sufficient for some practical decisions, but studying behaviour without asking how change occurs limits treatment development, transfer and relapse prevention. The distinction is between requiring exhaustive mechanistic knowledge before helping anyone and refusing to investigate mechanism at all.

Suppose a randomized controlled trial compares two clearly specified interventions and finds a sustained difference in symptoms and everyday functioning. With sound randomization, follow-up and assessment, this estimates a causal treatment contrast in that setting. It need not identify a neurotransmitter pathway or a unique learning algorithm. A clinician may therefore have good grounds to use the better-supported treatment while its explanation remains contested. Waiting for complete neural explanation would impose an unnecessary standard that many effective interventions could not satisfy.

Exposure and response prevention provides a concrete case. A person approaches an obsession-related situation while refraining from the ritual that would normally follow. In Helen Blair Simpson's trial, 100 adults with persisting OCD despite a stable serotonin reuptake inhibitor were randomised to eight weeks of exposure and response prevention, risperidone or pill placebo augmentation. Exposure produced greater improvement than either pill condition. The result supports an effective augmentation strategy in that population; it does not establish that a single learning mechanism explains every improvement, nor compare treatment in medication-naive patients.^[ref]

An earlier trial led by Edna B. Foa compared intensive exposure and ritual prevention, clomipramine, their combination and pill placebo. Its design separates clinically important treatment packages. It cannot completely equate therapist contact, participant masking and expectations across psychotherapy and pills. Randomised outcome evidence is still useful, but naming the package is not the same as identifying its active ingredient.^[ref]

Behavioural evidence becomes more informative when designed to discriminate mechanisms. Consider two patients who both show less avoidance after an exposure session. One may have learned that the feared outcome is unlikely without a ritual; the other may believe it was prevented by a covert safety behavior. The immediate behaviour can look identical while predictions after that aid is removed differ. Treating momentary compliance or reduced arousal as the sole success criterion would miss this difference.

The experiment by Peter F. Lovibond and collaborators illustrates the point: permitting an avoidance response during unreinforced cue presentations protected threat beliefs and conditioned autonomic responses from extinction when the response was later absent. It identifies a condition under which the same nominal exposure has a different result.^[ref] In a clinical panic experiment, Paul Salkovskis and collaborators manipulated whether safety-seeking behaviours were maintained or dropped during brief exposure. Dropping them improved the subsequent test outcomes, supporting the importance of how a patient interprets the exposure experience.^[ref]

These are mechanistic investigations even though their main measurements are behavioural. Mechanism need not mean a brain scan. Manipulating a contingency, testing outcome devaluation or checking whether a learned response transfers to a new context can distinguish information-processing accounts. Conversely, a neural correlate is not automatically a mechanism: a brain response can be an effect, a compensatory process or a correlate of an unmeasured cause.

Return of fear illustrates why a single endpoint is insufficient. In context-shift experiments, fear renewed outside the extinction context despite successful response reduction during extinction. Such results motivate testing a treatment across settings, delays and new cues. They constrain an erasure interpretation and explain why learning that is acquired in the clinic may not be retrieved at home.^[ref]

Mechanism claims nevertheless require stricter tests than observing that a proposed mediator and symptoms both improve. Therapist alliance, expectations and initial severity can influence both. Measuring the candidate mediator before symptom change, controlling baseline values and experimentally manipulating that component improves causal inference. Measurement error and unmeasured mediator–outcome confounding remain problems even in a trial where treatment itself was randomised.

The best programme alternates pragmatic comparisons with targeted experiments. First establish meaningful benefit and harms, then isolate components with dismantling or factorial designs, measure proposed processes and test predicted boundary conditions. Mechanistic insight should earn its place by improving prediction, personalisation or durable treatment effects, not by supplying attractive terminology. Outcomes justify the claim that an intervention works; experiments on mechanism explain when it works, what to preserve and what to change when it fails.